Literature DB >> 12119636

The health at any size paradigm for obesity treatment: the scientific evidence.

W C Miller1, A V Jacob.   

Abstract

Traditional weight loss (TWL) treatments have been unsuccessful at reducing the prevalence of obesity in the population. Health-care professionals and consumers have criticized TWL treatments as being detrimental to the obese person's health. Consequently, an alternative approach to obesity treatment, the health at any size (H@AS) paradigm, has been proposed. The H@AS paradigm is based on the philosophy that once diet restrictions and barriers to activity have been removed, the individual will develop healthier eating and activity patterns that lead to a naturally healthy body weight. This paper reviews the philosophical foundation and the scientific data that support and oppose the H@AS paradigm and compares it with that of TWL treatments.

Entities:  

Mesh:

Year:  2001        PMID: 12119636     DOI: 10.1046/j.1467-789x.2001.00023.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  4 in total

Review 1.  Effective diet and exercise treatments for overweight and recommendations for intervention.

Authors:  W C Miller
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  [Does bariatric surgery affect addiction to overeating and eating disorders?].

Authors:  E Ardelt-Gattinger; M Meindl; H Mangge; M Neubauer; S Ring-Dimitriou; J Spendlingwimmer; L Thun-Hohenstein; D Weghuber; K Miller
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

3.  The ups and downs of lifestyle modification: An existential journey among persons with severe obesity.

Authors:  Bente Skovsby Toft; Ulrica Hörberg; Birgit Rasmussen
Journal:  Scand J Caring Sci       Date:  2021-05-04

4.  Effects of a Multi-Disciplinary Lifestyle Intervention on Cardiometabolic Risk Factors in Young Women with Abdominal Obesity: A Randomised Controlled Trial.

Authors:  Bianca L Share; Geraldine A Naughton; Philippe Obert; Jennifer K Peat; Elizabeth A Aumand; Justin G Kemp
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.